drugset / Trial / NCT00234962

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

NCT00234962 ↗

Phase 4 Terminated 200 enrolled Abbott
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of adherence on HIV antiviral response to treatment regimens containing Kaletra or other HIV protease inhibitors.

Timeline

Start
2002-08
Primary completion
—
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lopinavir/Ritonavir Unknown — —